|
Volumn 53, Issue SUPPL. 1, 2005, Pages 216-229
|
Late phase II study of doripenem in urological infections
a
a
KOBE UNIVERSITY
(Japan)
|
Author keywords
Complication; Cystitis; Doripenem; Late phase II study; Pyelonephritis
|
Indexed keywords
CEFTAZIDIME;
DORIPENEM;
IMIPENEM;
MEROPENEM;
ACUTE PYELONEPHRITIS;
ADULT;
AGED;
ARTICLE;
BACTERIAL STRAIN;
BACTERIUM ISOLATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYSTITIS;
DRUG BLOOD LEVEL;
DRUG DISTRIBUTION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TISSUE LEVEL;
EPIDIDYMITIS;
ERADICATION THERAPY;
FEMALE;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
MALE;
OPEN STUDY;
PHASE 2 CLINICAL TRIAL;
PROSTATE;
PROSTATECTOMY;
PROSTATITIS;
SIDE EFFECT;
SINGLE DRUG DOSE;
TISSUE DISTRIBUTION;
URINARY TRACT INFECTION;
|
EID: 23244445500
PISSN: 13407007
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (11)
|